Spots Global Cancer Trial Database for haematology
Every month we try and update this database with for haematology cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX | NCT00590213 | Prostate Cancer | Casodex 150mg Radiotherapy Haematology | 18 Years - | AstraZeneca | |
| Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) | NCT01147939 | Acute Myeloid L... | Elacytarabine Investigator's ... | 18 Years - | Clavis Pharma | |
| Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) | NCT01147939 | Acute Myeloid L... | Elacytarabine Investigator's ... | 18 Years - | Clavis Pharma | |
| A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer | NCT00590278 | Inoperable or R... | Tomudex Radiotherapy Haematology Biochemistry | 18 Years - | AstraZeneca | |
| Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa | NCT00432913 | Adenomatous Pol... | Eicosapentaenoi... Endoscopy Biopsies taken Clinical chemis... Haematology Physical examin... Vital signs Urine pregnancy... Completion of p... | 18 Years - | S.L.A. Pharma AG | |
| Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) | NCT01147939 | Acute Myeloid L... | Elacytarabine Investigator's ... | 18 Years - | Clavis Pharma | |
| A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. | NCT01236144 | Acute Myeloid L... High Risk Myelo... | Plerixafor AC220 Ganetespib | 60 Years - | Cardiff University | |
| Atrial Fibrillation in Patients Receiving Ibrutinib | NCT04407845 | Leukemia, Chron... Mantle Cell Lym... | 18 Years - | European Georges Pompidou Hospital | ||
| A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia | NCT00866762 | Polycythemia Ve... Essential Throm... | HDAC inhibitor ... | 18 Years - | Copenhagen University Hospital at Herlev | |
| Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematology Care Units | NCT04174053 | Haematological ... | Enteric capsule | 18 Years - | Centre Henri Becquerel | |
| A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. | NCT01236144 | Acute Myeloid L... High Risk Myelo... | Plerixafor AC220 Ganetespib | 60 Years - | Cardiff University | |
| Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? | NCT00892502 | Hematological D... Hematological M... Blood Diseases Malignant Lymph... Leukemia Multiple Myelom... | Bismuth tablets Placebo tablets | 18 Years - 75 Years | Copenhagen University Hospital at Herlev | |
| Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX | NCT00590213 | Prostate Cancer | Casodex 150mg Radiotherapy Haematology | 18 Years - | AstraZeneca |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
